{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:08:24Z","timestamp":1787314104046,"version":"build-2736575974"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"5","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Venous thromboembolism (VTE) is a severe complication associated with cesarean delivery (c.d.). The risk of VTE has been estimated to be 2\u20134-fold higher compared to vaginal delivery and appears independent of other risk factors. Pharmacologic thromboprophylaxis after c.d. represents a daily challenge for obstetricians and is a common practice in many countries such as in Germany. However, the evidence of thromboprophylaxis efficacy is based on only four randomized controlled trials and one prospective cohort study. Risk assessment models to predict VTE after c.d. have not adequately been validated. According to meta-analyses pharmacologic thromboprophylaxis was not associated with a significant reduction in the risk of VTE\u00a0but is associated with an increased risk of bleeding and\u00a0hematomas compared to placebo. Due to the lack of evidence current guidelines differ markedly regarding recommendations on post-cesarean pharmacologic thromboprophylaxis. Most guidelines recommend no pharmacologic thromboprophylaxis after elective c.d. in the absence of additional VTE risk factors. In case of additional risk factors associated with elective c.d. as well as in case of emergency c.d. pharmacologic prophylaxis is advised for 7\u201310\u00a0days after delivery, and for at least 6\u00a0weeks after c.d. in high-risk patients. In view of the great number of various risk factors, the challenge not recognizing all risk factors timely and the low incidence of serious complications associated with the use of low molecular weight heparin (LMWH), we consent with others to suggest universal LMWH prophylaxis following c.d. rather than a selective being aware that universal LMWH prophylaxis is associated with significantly higher costs.<\/jats:p>","DOI":"10.1515\/jpm-2025-0041","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T03:07:24Z","timestamp":1742785644000},"page":"553-560","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacologic thromboprophylaxis following cesarean delivery-what is the evidence? A critical reappraisal"],"prefix":"10.1515","volume":"53","author":[{"given":"Werner","family":"Rath","sequence":"first","affiliation":[{"name":"Department of Obstetrics , RWTH Aachen, University Hospital , Aachen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Tsikouras","sequence":"additional","affiliation":[{"name":"Department of Obstetrics , Hospital of Alexandroupolis, Democritus University of Thrace , Alexandroupolis , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Pecks","sequence":"additional","affiliation":[{"name":"Department of Obstetrics , W\u00fcrzburg University hospital , W\u00fcrzburg , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"2025060211104098438_j_jpm-2025-0041_ref_001","doi-asserted-by":"crossref","unstructured":"Batr\u00e1n, AP, Ye, J, Moller, AB, Zhang, J, G\u00fclmezoglu, AM, Torloni, MP. The increasing trend to caesarean section rates. Global, regional and national estimates 1990\u20132014. PLoS One 2016;11:e0148343. https:\/\/doi.org\/10.1371\/journal.pone.0148343.","DOI":"10.1371\/journal.pone.0148343"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_002","unstructured":"IQTIG-insitut f\u00fcr qualit\u00e4tssicherung und transparenz im gesundheitswesen: Basisauswertung Geburtshilfe; 2023. http:\/\/iqtig.org."},{"key":"2025060211104098438_j_jpm-2025-0041_ref_003","doi-asserted-by":"crossref","unstructured":"Andrew, L, Ainle, FN, Blondon, M, Rudiger, MA, Skeith, L. Preventing postpartum venous thromboembolism: a call to active to reduce undue maternal morbidity and mortality. Thromb Res 2020;193:190\u20137.","DOI":"10.1016\/j.thromres.2020.07.007"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_004","doi-asserted-by":"crossref","unstructured":"Rath, WH, Stelzl, P. Strategies for the prevention of maternal death from venous thromboembolism: clinical recommendations based on current literature. J Perinat Med 2023;51:213\u201318. https:\/\/doi.org\/10.1515\/jpm-2022-0069.","DOI":"10.1515\/jpm-2022-0069"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_005","doi-asserted-by":"crossref","unstructured":"Bates, SM, Middeldorp, S, R\u00fcdiger, M, James, AH, Greer, I. Guidance for the treatment and prevention of obstetric-related venous thromboembolism. J Thromb Thrombolysis 2016;41:92\u2013128.","DOI":"10.1007\/s11239-015-1309-0"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_006","doi-asserted-by":"crossref","unstructured":"Kamel, H, Navi, BB, Sriram, N, Hovsepian, DA, Devereux, RB, Elkind, MS. Risk of thrombotic event after the 6-week postparum period. N Engl J Med 2014;370:1307\u201315. https:\/\/doi.org\/10.1056\/nejmoa1311485.","DOI":"10.1056\/NEJMoa1311485"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_007","doi-asserted-by":"crossref","unstructured":"Tepper, NK, Boulet, SL, Whiteman, MK, Monsour, M, Marchbanks, PA, Hooper, WC, et al.. Postpartum venous thromboembolism incidence and risk factors. Obstet Gynecol 2014;123:987\u201396. https:\/\/doi.org\/10.1097\/aog.0000000000000230.","DOI":"10.1097\/AOG.0000000000000230"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_008","doi-asserted-by":"crossref","unstructured":"Galambosi, PJ, Gissler, M, Kaaja, RJ, Ulander, VM. Incidence and risk factors of venous thromboembolism during postpartum period: a population-based cohort-study. Acta Obstet Gynecol Scand 2017;96:852\u201361. https:\/\/doi.org\/10.1111\/aogs.13137.","DOI":"10.1111\/aogs.13137"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_009","doi-asserted-by":"crossref","unstructured":"Abdul Sultan, A, Grainge, MJ, West, J, Fleming, KM, Nelson-Piercy, C, Tata, LJ. Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England. Blood 2014;124:2872\u201380. https:\/\/doi.org\/10.1182\/blood-2014-05-572834.","DOI":"10.1182\/blood-2014-05-572834"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_010","doi-asserted-by":"crossref","unstructured":"Blondon, M, Casini, A, Hoppe, KK, Boehlen, F, Righini, M, Smith, NL. Risk of venous thromboembolism after cesarean sections\u00a0\u2013 a meta-analysis. Chest 2016;150:572\u201396. https:\/\/doi.org\/10.1016\/j.chest.2016.05.021.","DOI":"10.1016\/j.chest.2016.05.021"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_011","doi-asserted-by":"crossref","unstructured":"He, L, Liu, J, Sun, R, Qiu, L, Gao, Y. Risk factors related to venous thromboembolism in pregnant women: a meta-analysis. Int Angiol 2024;43:323\u201330. https:\/\/doi.org\/10.23736\/s0392-9590.24.05141-1.","DOI":"10.23736\/S0392-9590.24.05141-1"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_012","doi-asserted-by":"crossref","unstructured":"Hart, C, Bauersachs, R, Scholz, K, Zutz, R, Bergmann, F, Roth, H, et al.. Prevention of venous thromboembolism during pregnancy and the puerperium with a specific focus on women with hereditary thrombophilia or prior VTE\u00a0\u2013 Position paper of the working group in women\u2019s health of the society of thrombosis and haemostasis (GTH). H\u00e4mostaseologie 2020;40:572\u201390. https:\/\/doi.org\/10.1055\/a-1132-0750.","DOI":"10.1055\/a-1132-0750"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_013","unstructured":"Zhang, Y, Chen, H, Zhuang, X, Lin, S, Lin, X. Risk factors analysis and clinical diagnosis on treatment of lower extremity deep venous thrombosis during pregnancy and puerperal period. J Vasc Endovasc Surg 2018;4:339\u201343."},{"key":"2025060211104098438_j_jpm-2025-0041_ref_014","doi-asserted-by":"crossref","unstructured":"Park, JE, Park, Y, Yuk, J-S. Incidence of and risk factors for thromboembolism during pregnancy and postpartum: a 10-year nationwide population-based study. Taiwanese J Obstet Gynecol 2021;60:103\u201310. https:\/\/doi.org\/10.1016\/j.tjog.2020.11.016.","DOI":"10.1016\/j.tjog.2020.11.016"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_015","doi-asserted-by":"crossref","unstructured":"Federspiel, JJ, Wein, LE, Duggal, R, Myers, ER, Bogess, KA, James, AH. Projected impact of guidelines on incidence of venous thromboembolism after cesarean delivery in the United States. J Thromb Haemost 2023;21:3547\u201356. https:\/\/doi.org\/10.1016\/j.jtha.2023.08.010.","DOI":"10.1016\/j.jtha.2023.08.010"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_016","doi-asserted-by":"crossref","unstructured":"Blondon, M. Thromboprophylaxis after cesarean section: decision analysis. Thromb Res 2011;127:S9\u201312. https:\/\/doi.org\/10.1016\/s0049-3848(11)70004-4.","DOI":"10.1016\/S0049-3848(11)70004-4"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_017","doi-asserted-by":"crossref","unstructured":"Seeho, SKM, Nippita, TA, Roberto, CL, Morris, JM, Nassar, N. Venous thromboembolism prophylaxis during and following caesarean section: a survey of clinical practice. Aust N Z J Obstet Gynaecol 2016;56:54\u20139. https:\/\/doi.org\/10.1111\/ajo.12393.","DOI":"10.1111\/ajo.12393"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_018","doi-asserted-by":"crossref","unstructured":"Donelly, JC, Raglan, GB, Bonnano, C, Schulkin, J, D\u2019Alton, ME. Practice pattern and preferences of obstetricians and gynaecologists regarding thromboprophylaxis at the time of cesarean section. J Matern Fetal Neonatal Med 2014;27:1870\u20133. https:\/\/doi.org\/10.3109\/14767058.2014.898057.","DOI":"10.3109\/14767058.2014.898057"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_019","doi-asserted-by":"crossref","unstructured":"Goecke, T, Voigt, F, Rath, W. Thromboprophylaxis following cesarean section\u00a0\u2013 a nation-wide survey from Germany. J Matern Fetal Neonatal Med 2020;33:2359\u201365. https:\/\/doi.org\/10.1080\/14767058.2018.1550064.","DOI":"10.1080\/14767058.2018.1550064"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_020","doi-asserted-by":"crossref","unstructured":"Burrows, RF, Gan, ET, Gallus, AS, Walace, EM, Burrows, EA. A randomized double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombotic events after caesarean section: a pilot study. BJOG 2001;108:835\u20139. https:\/\/doi.org\/10.1111\/j.1471-0528.2001.00198.x.","DOI":"10.1111\/j.1471-0528.2001.00198.x"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_021","doi-asserted-by":"crossref","unstructured":"Farjah Algahtani, AD, Saul, AH, Gader, AGA, Aamer, A. CO 327: thromboembolism prophylaxis after cesarean section (PRO-CS) trial. Thromb Res 2012;130:S197.","DOI":"10.1016\/j.thromres.2012.08.253"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_022","doi-asserted-by":"crossref","unstructured":"Gates, S, Brocklehorst, P, Ayers, S, Bowler, U. Thromboprophylaxis in pregnancy Advising Group. Thromboprophlaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin. AJOG 2004;191:1296\u2013303.","DOI":"10.1016\/j.ajog.2004.03.039"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_023","unstructured":"Heilmann, L, Rath, W, Pollow, K, Bick, RL. The rheological changes after cesarean section: the influence of low molecular weight heparin on unfractionated heparin on the rheological properties of blood. Clin Hemorheol Microcirc 2007;37:211\u201318."},{"key":"2025060211104098438_j_jpm-2025-0041_ref_024","doi-asserted-by":"crossref","unstructured":"Gizzo, S, Noventa, M, Anis, O, Saccardi, C, Zambon, A, Di Gangi, S, et al.. Pharmacological anti-thrombotic prophylaxis after elective caesarean delivery in thrombophilia unscreened women: should maternal age have a role in decision-making? J Perinat Med 2014;42:339\u201347. https:\/\/doi.org\/10.1515\/jpm-2013-0160.","DOI":"10.1515\/jpm-2013-0160"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_026","doi-asserted-by":"crossref","unstructured":"Middleton, P, Shephard, E, Gomersall, JC. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period (Review). Cochrane Database Syst Rev 2021;3:CD001689.","DOI":"10.1002\/14651858.CD001689.pub4"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_027","doi-asserted-by":"crossref","unstructured":"Ellison, J, Thomson, AJ, Conkie, JA, Mc Call, F, Walter, D, Greer, A. Thromboprophylaxis following caesarean section\u00a0\u2013 A comparison of the antithrombotic properties of three low molecular weight heparin-dalteparin, enoxaparin and tinzaparin. Thromb Haemost 2001;86:1374\u20138. https:\/\/doi.org\/10.1055\/s-0037-1616738.","DOI":"10.1055\/s-0037-1616738"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_028","doi-asserted-by":"crossref","unstructured":"Cruz, M, Fernandez-Alonso, AM, Rodriguez, J, Garriga, L, Cano, A, Carretero, P, et al.. Post cesarean thromboprophylaxis with two different regimens of bemiparin. Obstet Gynaecol Int 2011;26:548327.","DOI":"10.1155\/2011\/548327"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_029","doi-asserted-by":"crossref","unstructured":"Bruno, AM, Allshouse, AA, Campbell, HM, Zweig, DW, Lim, MY, Silber, RM, et al.. Weight-based versus fixed dose enoxaparin prophylaxis after cesarean delivery: a randomized controlled trial. Obstet Gynecol 2022;140:575\u201383. https:\/\/doi.org\/10.1097\/AOG.0000000000004937.","DOI":"10.1097\/AOG.0000000000004937"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_030","doi-asserted-by":"crossref","unstructured":"Stephenson, ML, Serra, AE, Neeper, JM, Caballero, DC, Mc Nulty, J. A randomized controlled trial of differing doses of postcesarean enoxaparin thromboprophylaxis in obese women. J Perinatol 2016;36:95\u20139. https:\/\/doi.org\/10.1038\/jp.2015.130.","DOI":"10.1038\/jp.2015.130"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_031","doi-asserted-by":"crossref","unstructured":"Overcash, RT, Somers, AT, La Coursiere, DY. Enoxaparin dosing after cesarean delivery in morbidity obese women. Obstet Gynecol 2015;125:1371\u20136.","DOI":"10.1097\/AOG.0000000000000873"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_032","doi-asserted-by":"crossref","unstructured":"Davis, S, Pandor, A, Sampson, FC, Hamilton, J, Nelson-Piercy, C, Hunt, BJ, et al.. Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research. Health Technol Assess 2024;28:1\u2013176. https:\/\/doi.org\/10.3310\/dfwt3873.","DOI":"10.3310\/DFWT3873"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_033","doi-asserted-by":"crossref","unstructured":"Cavazza, S, Rainald, MP, Adduci, A, Palaretti, G. Thromboprophylaxis following cesarean delivery: one size postpartum study to evaluate the application of a risk model. Thromb Res 2012;129:28\u201331.","DOI":"10.1016\/j.thromres.2011.06.028"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_034","doi-asserted-by":"crossref","unstructured":"Lok, WY, Kong, CW, To, WWK. A local risk model for venous thromboembolism prophylaxis for caesarean section in Chinese Women and comparison with international guidelines. Taiwan J Obst Gynecol 2019;58:520\u20135. https:\/\/doi.org\/10.1016\/j.tjog.2019.05.016.","DOI":"10.1016\/j.tjog.2019.05.016"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_035","doi-asserted-by":"crossref","unstructured":"Kawaguchi, R, Maehana, T, Yamada, Y, Ichikawa, M, Akasaka, J, Kimura, F. Verification of selective and individual pulmonary thromboembolism prophylaxes for cesarean delivery. Obstet Gynecol Sci 2023;66:181\u20139. https:\/\/doi.org\/10.5468\/ogs.22281.","DOI":"10.5468\/ogs.22281"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_036","doi-asserted-by":"crossref","unstructured":"Palmerola, LK, D\u2019Alton, ME, Bruck, CO, Friedman, AM. A comparison of recommendations for pharmacologic thromboembolism prophylaxis after cesarean delivery from three major guidelines. BJOG 2016;123:217\u20132162.","DOI":"10.1111\/1471-0528.13706"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_037","doi-asserted-by":"crossref","unstructured":"Kotaska, A. Postpartum venous thromboembolism prophylaxis may cause more harm than benefit: a critical analysis of international guidelines through an evidence-based lens. BJOG 2018;125:1109\u201316. https:\/\/doi.org\/10.1111\/1471-0528.15150.","DOI":"10.1111\/1471-0528.15150"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_038","doi-asserted-by":"crossref","unstructured":"Zheng, J, Chen, Q, Fu, J, Lu, Y, Han, T, He, P. Critical appraisal of international guidelines for the prevention and treatment of pregnancy-associated venous thromboembolism: a systematic review. BMC Cardiovasc Dis 2019;19:199. https:\/\/doi.org\/10.1186\/s12872-019-1183-3.","DOI":"10.1186\/s12872-019-1183-3"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_039","doi-asserted-by":"crossref","unstructured":"Federspiel, J, Wein, LE, Addae-Konadu, KL, Darwin, KC, Talamo, LE, Myers, ER, et al.. Venous thromboembolism incidence among patients recommended for pharmacologic thromboembolism prophylaxis after cesarean delivery in selected guidelines. J Thromb Haemost 2020;19:830\u20138. https:\/\/doi.org\/10.1111\/jth.15218.","DOI":"10.1111\/jth.15218"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_040","doi-asserted-by":"crossref","unstructured":"Friedman, AM, D\u2019Alton, ME. Expert review: prevention of obstetrical venous thromboembolism. AJOG 2021;225:228\u201336. https:\/\/doi.org\/10.1016\/j.ajog.2021.05.004.","DOI":"10.1016\/j.ajog.2021.05.004"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_041","doi-asserted-by":"crossref","unstructured":"Seeho, S, Nassar, N. Thromboprophylaxis after cesarean: when even the \u2018experts\u2019 disagree. BJOG 2015;123:2163. https:\/\/doi.org\/10.1111\/1471-0528.13740.","DOI":"10.1111\/1471-0528.13740"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_042","doi-asserted-by":"crossref","unstructured":"Villani, M, Ageno, W, Grandone, E, Dentali, F. The prevention and treatment of venous thromboembolism in pregnancy. Expert Rev Cardiovasc Ther 2017;15:397\u2013402. https:\/\/doi.org\/10.1080\/14779072.2017.1319279.","DOI":"10.1080\/14779072.2017.1319279"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_049","doi-asserted-by":"crossref","unstructured":"Bates, SM, Rajasekhari, A, Middledorp, S, Mc Lintock, C, Rodger, MA, James, AH, et al.. American society of hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv 2018;2:3317\u201359. https:\/\/doi.org\/10.1182\/bloodadvances.2018024802.","DOI":"10.1182\/bloodadvances.2018024802"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_043","doi-asserted-by":"crossref","unstructured":"Chen, WS, Rey, E, Kent, WE. Society of Obstetricians and Gynaecologists Clinical Practice Guideline No. 308. Venous thromboembolism and anti-thrombotic therapy in pregnancy. J Obstet Gynecol Can 2014;36:527\u201353. https:\/\/doi.org\/10.1016\/s1701-2163(15)30569-7.","DOI":"10.1016\/S1701-2163(15)30569-7"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_044","unstructured":"Royal College of Obstetricians and Gynaecologists. Reducing the risk of venous thromboembolism during pregnancy and the puerperium: green-top Guideline No. 37a. London-RCOG; 2015. Available from: https:\/\/www.rcog.org.uk\/media\/qejthcaj\/gtg-3ta.pdf."},{"key":"2025060211104098438_j_jpm-2025-0041_ref_045","doi-asserted-by":"crossref","unstructured":"Bates, SM, Greer, IM, Middeldorp, S, Veenstra, DL, Prabulos, AM, Vandvik, PC. VTE, thrombophilia, antithrombotic therapy and prevention of thrombosis. American college of chest physicians based clinical guidelines. Chest 2012;141:e691S\u2013736S. https:\/\/doi.org\/10.1378\/chest.11-2300.","DOI":"10.1378\/chest.11-2300"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_046","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. ACOG practice bulletin No. 196. Thromboembolism in pregnancy. Obstet Gynecol 2018;132:e1\u201317. https:\/\/doi.org\/10.1097\/AOG.0000000000002706.","DOI":"10.1097\/AOG.0000000000002706"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_047","doi-asserted-by":"crossref","unstructured":"Ducloy-Bouthors, A-S, Baldini, A, Abdul-Kadir, R, Nizard J for the ESA VTE Guideline Task Force. European guidelines on perioperative venous thromboembolism prophylaxis. Surgery during pregnancy and the immediate postpartum period. Eur J Anaesthesiol 2018;35:130\u20133. https:\/\/doi.org\/10.1097\/eja.0000000000000704.","DOI":"10.1097\/EJA.0000000000000704"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_048","doi-asserted-by":"crossref","unstructured":"Pacheco, LD, Saade, G, Metz, TD. Society for maternal-fetal medicine (SMFM): society for maternal-fetal medicine consult series #51: thromboembolism prophylaxis for cesarean delivery. AJOG 2020;223:B11\u20137. https:\/\/doi.org\/10.1016\/j.ajog.2020.04.032.","DOI":"10.1016\/j.ajog.2020.04.032"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_025","doi-asserted-by":"crossref","unstructured":"Yang, R, Zhao, X, Yang, Y, Huang, X, Li, H, Su, L. The efficacy and safety of pharmacological thromboprophylaxis following caesarean section: a systematic review and meta-analysis. PLoS One 2018;13:e0208725. https:\/\/doi.org\/10.1371\/journal.pone.0208725.","DOI":"10.1371\/journal.pone.0208725"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_050","doi-asserted-by":"crossref","unstructured":"Pandor, A, Darn, J, Hunt, BJ, Rooney, G, Hamilton, J, Clowes, M, et al.. Risk assessment models for venous thromboembolism in pregnancy and in the puerperium: a systematic review. BMJ Open 2022;12:e065892. https:\/\/doi.org\/10.1136\/bmjopen-2022-065892.","DOI":"10.1136\/bmjopen-2022-065892"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_051","doi-asserted-by":"crossref","unstructured":"Rath, W. General or selective medical thromboembolism prophylaxis after caesarean section. Z Geburtsh Neonatol 2014;218:183\u20134. https:\/\/doi.org\/10.1055\/s-0034-1390486.","DOI":"10.1055\/s-0034-1390486"},{"key":"2025060211104098438_j_jpm-2025-0041_ref_052","doi-asserted-by":"crossref","unstructured":"D\u2019Alton, ME, Friedman, AM, Smiley, RM, Montgomery, D, Paidas, MJ, D\u2019Oria, R, et al.. National partnership for maternal safety: Consensus bundle on venous thromboembolism. Obstet Gynecol 2016;128:688\u201398. https:\/\/doi.org\/10.1097\/aog.0000000000001579.","DOI":"10.1097\/AOG.0000000000001579"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0041\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0041\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T07:11:05Z","timestamp":1748848265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0041\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,8]]},"published-print":{"date-parts":[[2025,6,26]]}},"alternative-id":["10.1515\/jpm-2025-0041"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2025-0041","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]}}}